Fundraising Fox
/People
Sign in

Rachel Humphrey

Founder

Founding Chief Executive Officer at Normunity

Boston, Massachusetts, United States

FoundedNormunity

Find your path to Rachel

506 people in our graph share verified history with Rachel — schools, employers, funds. One of them is your warm intro.

Jeno GyurisunlockedRachel: together at Sporos Bioventures (2021–2023)
Rachel: together at Voro Therapeutics
×3Rachel: together at Normunity
Rachel: together at HotSpot Therapeutics

Founding Chief Executive Officer at Normunity

Intro paths

→

In turn, Rachel can intro founders to Normunity's investors below.

Normunity's investors · 11

Avoro Capital AdvisorsNew York · since 2025Canaan PartnersStamford · $500K – $20M checks · since 2025Connecticut InnovationsNew Haven · $500K – $2M checks · since 2025HongShan Capital GroupHong Kong · $100K – $50M checks · since 2025Osage Venture PartnersBala Cynwyd · $500K – $3M checks · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2025Samsara BioCapitalPalo Alto · since 2025Sanofi VenturesCambridge · $5M checks · since 2025Taiho Ventures, LLCMenlo Park · since 2025YK BioventuresBurlingame · since 2025

Co-founders at Normunity

LC
Lieping ChenScientific Founder

Experience

  1. Affibody ABIndependent Board Membercurrent2025 — presentStockholm, Stockholm County, Sweden
  2. Voro TherapeuticsChair of the Board of Directorscurrent2025 — present
  3. NormunityPresident and Founding CEOcurrent2021 — presentUnited States
  4. Pyxis OncologyIndependent Board Directorcurrent2022 — present
  5. Sporos BioventuresIndependent Board Directorcurrent2021 — present
  6. Grey Wolf TherapeuticsScientific Advisory Board Membercurrent2021 — presentGreater London, England, United Kingdom
  7. HotSpot Therapeutics, Inc.Scientific Advisory Board Membercurrent2021 — presentBoston, Massachusetts, United States
  8. Xilio Therapeutics, Inc.Independent Board Director2019 — 2022Cambridge, Massachusetts, United States
  9. Black Diamond TherapeuticsChief Medical Officer2020 — 2021Cambridge, Massachusetts, United States
  10. Treadwell Therapeutics, Inc.Board Director and Chief Medical Officer2020New York, New York
  11. TIO BioventuresHead Of Research And Development2020New York, New York
  12. CytomX TherapeuticsSVP, Chief Medical Officer2015 — 2019South San Francisco, CA
  13. CytomX TherapeuticsMember Board of Directors2015
  14. Eli Lilly and CompanyVice President, Head of Immuno-Oncology2015
  15. AstraZenecaSVP, Head of Immuno-Oncology2013 — 2014Gaithersburg, Maryland
  16. Mirati Therapeutics IncChief Medical Officer2012 — 2013San Diego, California and Princeton, NJ
  17. Bristol-Myers SquibbVice President, Development Lead, Immuno-oncology2004 — 2012Princeton, NJ
  18. Bristol-Myers SquibbExecutive Director, Global Research and Development2003 — 2004Wallingford, CT
  19. Bayer PharmaceuticalsDirector, Global Clinical Leader, R & D1997 — 2003West Haven, CT

Skills & more

Clinical DevelopmentOncologyPharmaceutical IndustryDrug Development78Clinical TrialsTranslational Medicine8Biomarkers34BiotechnologyMedical Affairs44Lifesciences9Drug Discovery31Immunology27
+8 moreClinical ResearchCancerTherapeutic AreasInfectious DiseasesCellCommercializationINDBiopharmaceuticals

Languages Hebrew

From Rachel's professional profile.

Frequently asked questions

Who is Rachel Humphrey?
Founding Chief Executive Officer at Normunity
Where does Rachel Humphrey work?
Rachel Humphrey is Founding Chief Executive Officer of Normunity.
What companies did Rachel Humphrey found?
Rachel Humphrey founded Normunity.
Where did Rachel Humphrey go to school?
Rachel Humphrey studied at The Johns Hopkins University School of Medicine (Residency, Internal Medicine); Case Western Reserve University School of Medicine (MD); Harvard University (BA, Biochemistry).

Founder mafias

Same school

Shared employers